Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to evaluate the effectiveness and safety of fedratinib as maintenance therapy in participants with myeloproliferative neoplasms (MPNs) after allogeneic hematopoietic cell transplant (HCT).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05127174
Study type Interventional
Source H. Lee Moffitt Cancer Center and Research Institute
Status Recruiting
Phase Phase 1/Phase 2
Start date November 9, 2021
Completion date November 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04022785 - PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Phase 1
Recruiting NCT03941769 - Recombinant Human Interleukin-7 to Promote T-Cell Recovery After Cord Blood Transplant Phase 1
Recruiting NCT04666025 - SARS-CoV-2 Donor-Recipient Immunity Transfer
Terminated NCT02877082 - Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients Phase 2
Recruiting NCT03589729 - Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers Phase 2
Active, not recruiting NCT03588078 - Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine Phase 1/Phase 2
Enrolling by invitation NCT04994158 - MASCOT Registry of Patients With Myeloproliferative Neoplasms Associated Splanchnic Vein Thrombosis
Completed NCT04192916 - Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
Not yet recruiting NCT03177928 - Cardiac Changes in Myeloproliferative Neoplasms N/A
Recruiting NCT04060277 - Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation Phase 2
Recruiting NCT04955938 - A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms Phase 1
Recruiting NCT04146038 - Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease Phase 2
Recruiting NCT02402244 - Project: Every Child for Younger Patients With Cancer
Recruiting NCT04605211 - A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors N/A
Not yet recruiting NCT04898790 - Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant N/A
Not yet recruiting NCT04902833 - Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Completed NCT02862366 - Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-
Recruiting NCT03630991 - Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy Phase 1
Recruiting NCT05053100 - Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Not yet recruiting NCT04527666 - Anticoagulation in Gastroesophageal Varices and JAK2 Mutation